Neuroblastoma trials in United States

In United States 59 Also abroad 128

59 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With Neuroblastoma
Where
New York
People
286
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT04936529
Phase 2Taking people
A Phase 2 Study Of Zanzalintinib For Patients With Recurrent Or Metastatic Olfactory Neuroblastoma
Where
Houston
Age
18 years and over
People
16
Run by
M.D. Anderson Cancer Center
See details and how to joinNCT07527169
Phase 1Taking people
A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
Where
Bethesda
Age
18 years to 120 years
People
70
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06041516
Phase 2Taking people
A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma
Where
Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Uniondale
People
100
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06057948
Phase 1/2Taking people
Testing the Addition of Iberdomide to Therapy in People With Neuroblastoma That Has Come Back, Not Responded to Treatment, or Gotten Worse
Where
Chicago, Columbia, New York, Oakland
Age
1 year to 30 years
People
76
Run by
National Cancer Institute (NCI)
See details and how to joinNCT07437963
No phaseTaking people
Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Where
Bethesda
Age
4 years and over
People
2,415
Run by
National Cancer Institute (NCI)
See details and how to joinNCT01005654
Phase 2Taking people
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
Where
Bethesda
Age
18 years to 120 years
People
40
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06176989
Phase 1Taking people
PEACH TRIAL- Precision Medicine and Adoptive Cellular Therapy
Where
Charlotte, Gainesville, Hershey
Age
1 year to 30 years
People
24
Run by
University of Florida
See details and how to joinNCT04837547
Phase 2/3Taking people
A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma Patients
Where
Aurora, Chicago, Dallas, Durham, Minneapolis, Philadelphia, San Francisco, The Bronx
Age
18 months to 18 years
People
144 worldwide
Run by
Renaissance Pharma Ltd.
See details and how to joinNCT07549321 · EU 2025-524397-42-00
Phase 3Taking people
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Where
Akron, Albany, Albuquerque, Allentown, Ann Arbor, Asheville, Atlanta, Aurora, Austin, Baltimore, Bangor, Bethesda, Birmingham, Boston, Buffalo, Burlington, Chapel Hill, Charleston, Charlotte, Charlottesville, Chicago, Cincinnati, Cleveland, Columbia, Columbus, Corpus Christi, Dallas, Danville, Dayton, Des Moines, Detroit, Downey, Duarte, Durham, El Paso, Fargo, Fort Lauderdale, Fort Myers, Fort Worth, Gainesville, Grand Rapids, Green Bay, Greenville, Hackensack, Hartford, Hollywood, Honolulu, Houston, Huntington, Indianapolis, Iowa City, Jackson, Jacksonville, Kalamazoo, Kansas City, Knoxville, Las Vegas, Lebanon, Lexington, Little Rock, Loma Linda, Long Beach, Los Angeles, Louisville, Lubbock, Madera, Madison, Marshfield, Memphis, Mesa, Miami, Milwaukee, Mineola, Minneapolis, Mobile, Morgantown, Morristown, Nashville, Newark, New Brunswick, New Haven, New Hyde Park, New Orleans, New York, Oakland, Oak Lawn, Oklahoma City, Omaha, Orange, Orlando, Palo Alto, Park Ridge, Paterson, Peoria, Philadelphia, Phoenix, Pittsburgh, Portland, Portsmouth, Providence, Rochester, Royal Oak, Sacramento, Salt Lake City, San Antonio, San Diego, San Francisco, Savannah, Scarborough, Seattle, Sioux Falls, Spokane, Springfield, St Louis, St. Petersburg, Syracuse, Tacoma, The Bronx, Toledo, Tucson, Tulsa, Valhalla, Washington D.C., West Palm Beach, Wichita, Wilmington, Winston-Salem
Age
Up to 30 years
People
478 worldwide
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06172296
Phase 1/2Taking people
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Where
Aurora, Boston, Fargo, Grand Rapids, Houston, Iowa City, Kansas City, Los Angeles, New Brunswick, New Haven, New York, Philadelphia, Portland, Salt Lake City, Sioux Falls, St. Petersburg, Valhalla
Age
6 months to 25 years
People
90 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00
Phase 1Taking people
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
Where
Madison
Age
7 months to 21 years
People
22
Run by
University of Wisconsin, Madison
See details and how to joinNCT02508038
Phase 2Taking people
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
Where
Minneapolis
Age
Up to 30 years
People
12
Run by
Masonic Cancer Center, University of Minnesota
See details and how to joinNCT02605421
No phaseTaking people
International PPB/DICER1 Registry
Where
Minneapolis
Age
0 Minutes to 100 years
People
3,400
Run by
Children's Hospitals and Clinics of Minnesota
See details and how to joinNCT03382158
Phase 1Taking people
Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma
Where
Bethesda
Age
3 years to 35 years
People
40
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06995872
No phaseTaking people
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies
Where
Bethesda, Charlotte, New York, Orange, Washington D.C.
Age
4 weeks and over
People
6,035
Run by
National Cancer Institute (NCI)
See details and how to joinNCT01109394
No phaseTaking people
A Natural History Study of Children and Adults With Olfactory Neuroblastoma
Where
Bethesda
Age
3 years to 120 years
People
525
Run by
National Cancer Institute (NCI)
See details and how to joinNCT04755205
Phase 1Taking people
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Where
Palo Alto
Age
1 year to 30 years
People
18
Run by
Stanford University
See details and how to joinNCT07087002
Phase 1Taking people
Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors
Where
Cincinnati, Dallas, Lubbock, Milwaukee, Oklahoma City
Age
12 months to 20 years
People
30
Run by
South Plains Oncology Consortium
See details and how to joinNCT02013336
Phase 1Taking people
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Where
Bethesda
Age
18 years to 120 years
People
120
Run by
National Cancer Institute (NCI)
See details and how to joinNCT06479811
Phase 1/2Taking people
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Where
Birmingham, Dallas, Detroit, Gainesville, Hackensack, Hartford, Hershey, Honolulu, Kansas City, Louisville, Miami, Nashville, Oakland, Orlando, Phoenix, Providence, Richmond, Sacramento, Salt Lake City, San Diego, St Louis, St. Petersburg, Tampa
Age
Up to 30 years
People
104 worldwide
Run by
Milton S. Hershey Medical Center
See details and how to joinNCT06541262
Phase 1/2Taking people
PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Where
Boston, Houston, Los Angeles, Philadelphia, Salt Lake City, San Francisco
Age
1 year to 30 years
People
59
Run by
Theodore Laetsch
See details and how to joinNCT06721689
No phaseTaking people
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
Where
New York
People
2,070
Run by
Memorial Sloan Kettering Cancer Center
See details and how to joinNCT00588068
No phaseTaking people
MCT for the Harvard/UCSF ROBIN Center
Where
Boston, San Francisco
People
47
Run by
Brigham and Women's Hospital
See details and how to joinNCT06000787
No phaseTaking people
Biomarkers of Resiliency In Childhood Cancer Surgery
Where
Rochester
Age
3 years to 25 years
People
40
Run by
Mayo Clinic
See details and how to joinNCT06674811